393 related articles for article (PubMed ID: 24994579)
1. Bone benefits of testosterone replacement therapy in male hypogonadism.
Tirabassi G; Biagioli A; Balercia G
Panminerva Med; 2014 Jun; 56(2):151-63. PubMed ID: 24994579
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.
Tirabassi G; Delli Muti N; Corona G; Maggi M; Balercia G
J Sex Med; 2014 May; 11(5):1302-8. PubMed ID: 24593124
[TBL] [Abstract][Full Text] [Related]
4. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
[TBL] [Abstract][Full Text] [Related]
5. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
6. [Testosterone and bone: indications and limitations].
Stoll D; Puder JJ; Lamy O
Rev Med Suisse; 2011 Jun; 7(299):1311-5. PubMed ID: 21793421
[TBL] [Abstract][Full Text] [Related]
7. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
8. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).
Shigehara K; Konaka H; Koh E; Nakashima K; Iijima M; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Sugimoto K; Iwamoto T; Mizokami A; Namiki M
Aging Male; 2017 Sep; 20(3):139-145. PubMed ID: 28347184
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk.
Maganty A; Osterberg EC; Ramasamy R
Am J Mens Health; 2015 Jul; 9(4):340-4. PubMed ID: 24972716
[TBL] [Abstract][Full Text] [Related]
10. Bone health in hypogonadal men.
Irwig MS
Curr Opin Urol; 2014 Nov; 24(6):608-13. PubMed ID: 25144148
[TBL] [Abstract][Full Text] [Related]
11. [Bone and Men's Health. Androgen replacement therapy and bone metabolism].
Ogawa S
Clin Calcium; 2010 Feb; 20(2):251-7. PubMed ID: 20118518
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis in older men: recent advances in pathophysiology and treatment.
Laurent M; Gielen E; Claessens F; Boonen S; Vanderschueren D
Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):527-39. PubMed ID: 24054929
[TBL] [Abstract][Full Text] [Related]
13. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
15. Testosterone, bone and osteoporosis.
Tuck S; Francis R
Front Horm Res; 2009; 37():123-132. PubMed ID: 19011293
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
17. Male hypogonadism and skeletal health.
Irwig MS
Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):517-22. PubMed ID: 24468754
[TBL] [Abstract][Full Text] [Related]
18. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of testosterone replacement therapy.
Zitzmann M
Pharmacogenomics; 2009 Aug; 10(8):1341-9. PubMed ID: 19663677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
